Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma

被引:8
|
作者
Korhonen, Niina [1 ,2 ]
Ylitalo, Leea [1 ,2 ,3 ]
Luukkaala, Tiina [4 ]
Itkonen, Julius [1 ,2 ]
Haihala, Henni [1 ,2 ]
Jernman, Juha [5 ,6 ]
Snellman, Erna [1 ,2 ]
Palve, Johanna [2 ,7 ]
机构
[1] Tampere Univ, Tampere Univ Hosp, Dept Dermatol & Allergol, Tampere, Finland
[2] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[3] Univ Helsinki, Skin Canc Unit, Dept Dermatol, Cent Hosp, Helsinki, Finland
[4] Tampere Univ, Tampere Univ Hosp & Hlth Sci, Res Dev & Innovat Ctr, Fac Social Sci, Tampere, Finland
[5] Tampere Univ, Dept Pathol, Tampere, Finland
[6] Fimlab Labs, Tampere, Finland
[7] Tampere Univ, Tampere Univ Hosp, Dept Plast Surg, Tampere, Finland
关键词
Cutaneous squamous cell carcinoma; Basal cell carcinoma; Cutaneous melanoma; Actinic keratosis; Bowen's disease; ACTINIC KERATOSIS; RISK; POPULATION; PREVALENCE; GUIDELINES; DIAGNOSIS; CONSENSUS;
D O I
10.1007/s00403-020-02114-w
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The incidence of keratinocyte carcinomas is increasing worldwide and currently there is no standardised strategy for the follow-up of patients with multiple tumours. The objective of this study was to assess the prevalence of premalignant lesions, i.e., actinic keratosis and Bowen's disease, as well as basal cell carcinoma (BCC) and cutaneous melanoma (CM) among patients with cutaneous squamous cell carcinoma (cSCC). Pathology database search was performed to identify all cSCC patients diagnosed in the Pirkanmaa region of Finland in 2006-2015. Details of the patients and tumours were obtained through medical record review. The cohort consisted of 774 patients with 1131 cSCC tumours. Overall 559 patients (72%) had premalignant lesions. A total of 316 patients (41%) had BCC and 52% of these (n = 164) had more than one BCC tumour. 50 patients (6%) had CM. Overall 180 cSCC patients (23%) had no premalignant changes, BCC or CM. The median age of these patients was 6 years less than that of the patients with premalignant lesions (p < 0.001) or BCC (p < 0.001). The invasion depth of the tumours was deeper in the patients with only cSCC (median 3 mm, interquartile range 2-6) than in those with premalignant lesions or BCC (median 2 mm, interquartile range 1-3),p < 0.001. CSCC patients have a high risk of developing multiple skin cancers and need long-term follow-up.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 50 条
  • [31] Cutaneous melanin density of caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin
    Dwyer, T
    Blizzard, L
    Ashbolt, R
    Plumb, J
    Berwick, M
    Stankovich, JM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (07) : 614 - 621
  • [32] Premalignant and early squamous cell carcinoma
    Butani, A
    Arbesfeld, DM
    Schwartz, RA
    [J]. CLINICS IN PLASTIC SURGERY, 2005, 32 (02) : 223 - +
  • [33] Squamous Cell Carcinoma Manifesting as Cutaneous Cystic Lesions
    Shah, Avnee
    Peloro, Tina M.
    Sauder, Daniel N.
    [J]. CUTIS, 2012, 89 (01): : 45 - 47
  • [34] Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study
    Sharp, Kelley
    Olafsdottir, Elinborg J.
    Sahni, Dev R.
    Madsen, Steve
    Grant-Kels, Jane M.
    Kristjansson, Arni
    Hoyt, David W.
    Ungar, Jonathan P.
    Frigerio, Alice
    Jonasson, Jon Gunnlaugur
    Adalsteinsson, Jonas A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 91 - 97
  • [35] Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma
    Chren, Mary-Margaret
    Sahay, Anju P.
    Bertenthal, Daniel S.
    Sen, Saunak
    Landefeld, C. Seth
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (06) : 1351 - 1357
  • [36] PERINEURAL INFILTRATION OF CUTANEOUS SQUAMOUS CELL CARCINOMA AND BASAL CELL CARCINOMA WITHOUT CLINICAL FEATURES
    Lin, Charles
    Tripcony, Lee
    Keller, Jacqui
    Poulsen, Michael
    Martin, Jarad
    Jackson, James
    Dickie, Graeme
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 334 - 340
  • [37] Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma
    Chang, A. S.
    Mohan, S.
    Chang, J.
    Wood, D.
    Henry, S.
    Li, S.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S28 - S28
  • [38] Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma
    Mohan, Shalini V.
    Chang, Julia
    Li, Shufeng
    Henry, A. Solomon
    Wood, Douglas J.
    Chang, Anne Lynn S.
    [J]. JAMA DERMATOLOGY, 2016, 152 (05) : 527 - 532
  • [39] Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx
    Yuge, T
    Nibu, K
    Kondo, K
    Shibahara, J
    Tayama, N
    Sugasawa, M
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2005, 114 (02): : 127 - 131
  • [40] Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma
    Zieba, Sebastian
    Pouwer, Anne-Floor W.
    Kowalik, Artur
    Zalewski, Kamil
    Rusetska, Natalia
    Bakula-Zalewska, Elwira
    Kopczynski, Janusz
    Pijnenborg, Johanna M. A.
    de Hullu, Joanne A.
    Kowalewska, Magdalena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 13